MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from the
exercise of stock options
$149K
Net cash provided by
financing activities
$149K
Net decrease in cash
and cash...
-$27,330K
Canceled cashflow
$149K
Stock-based compensation
$1,116K
Accounts receivable from
collaboration with related...
-$523K
Non-cash rent expense
$204K
Depreciation and
amortization
$26K
Proceeds from maturities
of marketable...
$57,600K
Net cash used in
operating activities
-$22,097K
Net cash (used in)
provided by investing...
-$5,382K
Canceled cashflow
$1,869K
Canceled cashflow
$57,600K
Collaboration revenue from a
related party
$8,213K
Interest and other
income, net
$2,291K
Net loss
-$9,079K
Deferred revenue from a
related party
-$7,828K
Other accrued
expenses
-$5,085K
Accrued research and
development expenses
-$849K
Purchases of marketable
securities
$62,963K
Canceled cashflow
$10,504K
Net accretion of
investments in marketable...
$789K
Operating lease
liabilities
-$202K
Prepaid expenses and
other current assets
$92K
Accounts payable
-$42K
Purchases of property and
equipment
$19K
Total research and
development
$14,900K
General and
administrative
$4,683K
Back
Back
Cash Flow
ASSEMBLY BIOSCIENCES, INC. (ASMB)
ASSEMBLY BIOSCIENCES, INC. (ASMB)
source: myfinsight.com